Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Elixir Department: SOP for Sample Retention Procedure – V 2.0

Posted on By

Elixir Department: SOP for Sample Retention Procedure – V 2.0

Standard Operating Procedure for Sample Retention Procedure in Elixir Manufacturing

Department Elixir Department
SOP No. SOP/ELX/239/2025
Supersedes SOP/ELX/239/2022
Page No. Page 1 of 7
Issue Date 11/04/2025
Effective Date 15/04/2025
Review Date 11/04/2026

1. Purpose

To establish a procedure for the retention of reference and stability samples of elixir formulations to support batch investigation, regulatory compliance, and quality monitoring throughout the product’s shelf-life.

2. Scope

This SOP applies to the Quality Control and Quality Assurance departments for the retention of raw materials, in-process materials, and finished product samples from commercial and development batches of elixirs.

3. Responsibilities

  • QC Analyst:
    • Collect and label samples as per the retention matrix.
    • Maintain storage conditions as defined in the SOP.
  • QA Officer:
    • Ensure traceability, documentation, and inspection of retained samples.
  • Warehouse Personnel:
    • Assist in allocation and identification of retained sample locations.
See also  Elixir Department: SOP for Verification of Final Product Volume - V 2.0

4. Accountability

The QA Head is accountable for ensuring compliance with retention requirements as per GMP and regulatory guidelines.

5. Procedure

5.1 Sample Types

  • Retention Sample: A representative sample of the batch stored for
future reference.
  • Stability Sample: A sample placed on an ongoing stability program as per ICH guidelines.
  • 5.2 Sample Quantity

    1. Retention sample: Sufficient quantity to perform complete retesting.
    2. Minimum of two commercial containers per batch (e.g., 2 × 100 mL bottles).
    3. Stability sample: As defined in the approved stability protocol.

    5.3 Sampling and Labeling

    1. Label must include:
      • Product name
      • Batch number
      • Manufacturing date
      • Expiry date
      • Sample type (Retention/Stability)
    2. Samples must be taken after final QC approval of the batch.

    5.4 Storage Conditions

    1. Store retention samples under labeled storage conditions (usually room temperature: 25°C ± 2°C / 60% RH ± 5%).
    2. Stability samples to be stored in validated chambers as per protocol.
    3. Ensure segregation of batches to avoid mix-ups.

    5.5 Retention Duration

    1. One year after expiry date or one year after batch release (whichever is longer).
    2. Raw material retention as per respective SOP or minimum of 2 years from receipt date.

    5.6 Disposal of Samples

    1. After the retention period, samples shall be destroyed following QA approval.
    2. Maintain disposal records with date, batch number, and disposal method.

    5.7 Documentation

    1. Record all samples in the Retained Sample Register (Annexure-1).
    2. Include storage location, shelf details, and inspection status.
    3. Update records during periodic audits or visual inspections.

    6. Abbreviations

    • SOP: Standard Operating Procedure
    • QC: Quality Control
    • QA: Quality Assurance
    • RH: Relative Humidity
    • ICH: International Council for Harmonisation

    7. Documents

    1. Retained Sample Register (Annexure-1)
    2. Stability Protocol
    3. Sample Disposal Log

    8. References

    • 21 CFR Part 211.170 – Reserve Samples
    • ICH Q1A(R2) – Stability Testing of New Drug Substances and Products
    • WHO GMP Guidelines for Pharmaceuticals

    9. SOP Version

    Version: 2.0

    10. Approval Section

    Prepared By Checked By Approved By
    Signature
    Date
    Name
    Designation
    Department

    11. Annexures

    Annexure-1: Retained Sample Register

    Date Product Name Batch No. Sample Type Storage Condition Location Checked By
    11/04/2025 Iron Elixir ELX-0425-055 Retention 25°C / 60% RH Shelf B3 Sunita Reddy

    Revision History:

    Revision Date Revision No. Revision Details Reason for Revision Approved By
    01/01/2024 1.0 Initial SOP Release New SOP Creation QA Head
    11/04/2025 2.0 Aligned with WHO GMP & added stability retention Regulatory Compliance QA Head
    See also  Elixir Department: SOP for In-Process Filter Integrity Testing - V 2.0
    Elixers V 2.0 Tags:Elixir colorants, Elixir dosage form, Elixir filtration techniques, Elixir flavoring agents, Elixir formulation, Elixir GMP compliance, Elixir manufacturing process, Elixir manufacturing SOPs, Elixir packaging requirements, Elixir pharmacopoeial standards, Elixir preparation methods, Elixir preservatives, Elixir production equipment, Elixir quality control, Elixir regulatory guidelines, Elixir shelf life, Elixir stability testing, Elixir sterilization methods, Elixir storage conditions, Elixir sweetening agents, Elixir viscosity modifiers, Hydroalcoholic solutions, Medicated elixirs, Non-medicated elixirs, Pharmaceutical elixirs

    Post navigation

    Previous Post: Analytical Method Development: SOP for Preparation and Approval of Working Standards – V 2.0
    Next Post: Analytical Method Development: SOP for Calibration of UV-Visible Spectrophotometer – V 2.0

    Standard Operating Procedures V 1.0

    • Aerosols
    • Analytical Method Development
    • Bioequivalence Bioavailability Study
    • Capsule Formulation
    • Clinical Studies
    • Creams
    • Data Integrity
    • Dental Dosage Forms
    • Drug Discovery
    • Environment, Health and Safety
    • Formulation Development
    • Gels
    • Good Distribution Practice
    • Good Warehousing Practices
    • In-Process Control
    • Injectables
    • Liquid Orals
    • Liposome and Emulsion Formulations
    • Lotions
    • Lyophilized Products
    • Maintenance Dept.
    • Medical Devices
    • Metered-Dose Inhaler
    • Microbiology Testing
    • Nanoparticle Formulation
    • Nasal Spray Formulations
    • Nebulizers
    • Ocular (Eye) Dosage Forms
    • Ointments
    • Otic (Ear) Dosage Forms
    • Pharmacovigilance
    • Powder & Granules
    • Purchase Departments
    • Quality Assurance
    • Quality Control
    • Raw Material Stores
    • Regulatory Affairs
    • Tablet Manufacturing
    • Rectal Dosage Forms
    • Transdermal Patches
    • Vaginal Dosage Forms
    • Validations and Qualifications

    Read SOPs in your Language:

     - 
    Bengali
     - 
    bn
    English
     - 
    en
    Gujarati
     - 
    gu
    Hindi
     - 
    hi
    Malayalam
     - 
    ml
    Marathi
     - 
    mr
    Punjabi
     - 
    pa
    Tamil
     - 
    ta
    Telugu
     - 
    te

    NEW! Revised SOPs – V 2.0

    • Aerosols V 2.0
    • Analytical Method Development V 2.0
    • API Manufacturing V 2.0
    • BA-BE Studies V 2.0
    • Biosimilars V 2.0
    • Capsules V 2.0
    • Creams V 2.0
    • Elixers V 2.0
    • Gels V 2.0
    • Injectables V 2.0
    • Ointments V 2.0
    • Raw Material Warehouse V 2.0
    • Tablet Manufacturing V2.0

    New Publication: A must for All.

    Copyright © 2026 SOP Guide for Pharma.

    Powered by PressBook WordPress theme

    Go to mobile version